Press release
XING AG invests in the midst of the crisis, boosts midyear revenues by 35 percent
• Total revenues increase by 35 percent to €21.54 million• 41 percent higher revenues from Premium Memberships
• Over 635,000 paying members around the world
• 21 percent growth for XING Jobs
• Key investments for new business models already made in H1
Hamburg, August 13, 2009 – XING AG (ISIN: DE000XNG888) today announced total revenues of €21.54 for the first six months of 2009. This is an increase of 35 percent over total revenues for H1/2008 (€15.91 million).
In the first six months of this financial year, the leading European business network gained over 900 thousand new members. At the beginning of August 2009, the XING membership base exceeded 8 million for the first time.
Alongside continued total membership growth, 85 thousand paying Premium Members were gained in H1/2009. As of June 30, 2009, XING numbered 635 thousand Premium Members, an increase of 35 percent over the previous year’s figures (H1/2008 470 thousand). Accordingly, the core business segment "Premium Memberships” generated 41 percent higher revenues in H1/2009 (€17.86 million) than in H1/2008 (€12.64 million), driving the Company’s considerable boost in total revenues.
Revenues from job listings also increased in H1/2009 to €2.23 million, a 21 percent boost over H1/2008 (€1.84 million). Despite an online job ad market heavily hit by the economic crisis, XING AG was able to sustainably boost revenues in this area, acquiring additional market share in this second key business segment.
Midyear EBITDA results increased slightly over those of the previous year, to €5.90 million in H1/2009 from €5.76 in H1/2008. Furthermore, XING AG has invested heavily in its own programming and development resources with the aim of launching new business models, products and features even faster in the future, and gaining new sources of revenues.
These investments in new business segments and in successful recruiting efforts for accelerating the speed of innovation are reflected in group results of €2.18 million for H1/2009, which are below those of the previous midyear results (€2.95 million), as expected.
“In the first six months of 2009, we’ve invested heavily in developing new business models, and made solid progress in working towards our strategic goals. In the second half of the year, we’ll continue to focus on making XING more appealing for our members, and also launch new sources of revenues. We have new functionalities especially for recruiters are already in the beta phase. In addition, we will continue to invest in the growth of membership figures in our European core markets,” explained Dr. Stefan Gross-Selbeck, CEO of XING AG.
About XING:
XING is the leading European online business network. Over 8 million members use XING in 16 languages to do business, find jobs, and pursue a career. XING helps members get connected and stay in touch with their contacts with customized networking solutions and services. Members are active on XING because of the real value generated, with XING Jobs, over 30 thousand specialized groups, and over 90 thousand live networking events a year, organized by members for members.
Since the 2006 IPO, the XING AG share has established a solid position for itself on the stock market, the first and to date only Web 2.0 company to do so. XING AG is headquartered in Hamburg, Germany, and has local offices in Barcelona, Istanbul and Milan.
XING. Powering Relationships.
Thorsten Vespermann
----------------------------
Director Corporate Communications
XING AG
Gaensemarkt 43
20354 Hamburg
Germany
+49 40-419131-763
press@xing.com
https://www.xing.com/profile/Thorsten_Vespermann/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release XING AG invests in the midst of the crisis, boosts midyear revenues by 35 percent here
News-ID: 92250 • Views: …
More Releases from XING AG
XING continues growth course
* 70% increase in EBITDA in Q1
* Two thirds of growth generated by new sources of revenue
* Strongest member growth in German-speaking countries since Q1 2009
Hamburg, May 10, 2011 – In the first quarter of 2011, XING AG successfully continued the growth course set during the 2010 financial year. The market leader in German-speaking countries reported an EBITDA of €5.6 million during Q1 2011, which represents an increase of 70%…
XING: Boards suggest special distribution of funds from capital reserves amounti …
Hamburg, March 30, 2011 - The Management and Supervisory Boards of XING AG, Hamburg (ISIN DE000XNG8888), have decided today to suggest paying a special distribution of funds from capital reserves amounting to €20 million to the company’s shareholders at the next AGM on May 26, 2011. The payout per share will amount to approx. €3.70.
Stefan Gross-Selbeck, CEO at XING AG, said: “This special distribution of funds highlights XING’s financial…
XING AG increases EBITDA by 52 percent in Q3/2010
XING AG increases EBITDA by 52 percent in Q3/2010
* EBITDA of €4.46 million - The highest operating result in the company’s history
* Revenues from services up by 20 percent
* 194 thousand new members in German-speaking countries
Hamburg, November 9, 2010 - In Q3/2010, XING AG reported an EBITDA of €4.46 million, the company’s highest ever operating result. This in turn equates to a 52 percent increase over Q3/2009 (€2.92…
XING makes successful start to financial year 2010
17 percent increase in revenue to €12.60 million
- €1.3 million profit
- EBITDA of €3.3 million
- 23 percent increase in member numbers compared to previous year
- 420,000 new members in Q1
Hamburg, May 12, 2010 - XING AG has made a successful start to the 2010 financial year with Q1 revenues of €12.60 million, which represents a 17 percent increase over figures for the same period last year (€10.75 million). This positive development…
More Releases for H1/2008
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape.
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up…
Acromegaly - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title India Airway Stenting Procedures Outlook to 2023 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly - Pipeline Review, H1 2017, provides an overview of the Acromegaly (Hormonal Disorders) pipeline landscape.
Acromegaly is a hormonal disorder that develops when pituitary gland produces too much growth hormone during adulthood. Symptoms include body…
Dyskinesia - Pipeline Review, H1 2017
MarketResearchReports.Biz presents this most up-to-date research on "Dyskinesia - Pipeline Review, H1 2017"
Description
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dyskinesia - Pipeline Review, H1 2017, provides an overview of the Dyskinesia (Central Nervous System) pipeline landscape.
Dyskinesia refers to the involuntary nature of muscular movements or the difficulty in performing voluntary muscular movement. Symptoms include facial grimacing, finger movement, jaw swinging, repetitive chewing and tongue thrusting. The disease…
Fibrosarcoma - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Fibrosarcoma - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrosarcoma – Pipeline Review, H1 2017, provides an overview of the Fibrosarcoma (Oncology) pipeline landscape.
Fibrosarcoma is a malignant tumor derived from fibrous connective tissue. Symptoms include local pain, local swelling, local warmth, dilated blood vessels pain…
Warts - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Warts- Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Warts - Pipeline Review, H1 2017, provides an overview of the Warts (Infectious Disease) pipeline landscape.
Warts are skin growth that is caused by virus called human papillomavirus (HPV). HPV infects the top layer of skin, usually entering…
Kreativ-Award 2008 (Creativity Award 2008) goes to: Audiogent
Interactive Audiobooks do not repeat themselves - usually. However - Audiogent received their sixth award this year.
In 2008, Audiogent received awards for innovation, business concept and their business plan on various occasions. At the end of the year the young scientists and entrepreneurs from Magdeburg obtained yet another prize: "Kreativ-Award 2008" (Creativity-Award 2008) of the Businessplanwettbewerb Sachsen-Anhalt, which was sponsored by the KfW-Mittelstandsbank.
The internationally operating company Audiogent takes the concept…